MedKoo Cat#: 464379 | Name: Myrtecaine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Myrtecaine (Nopoxamine), sold as a combination product with diethylamine salicylate under the trade name Algesal and Algésal Suractivé among others, is a local anaesthetic in the form of a topical cream, or with laurilsulfate in rubefacient preparations. It is used to treat muscle strains, tendinitis or ligament sprains and joint pain. It is a surface anaesthetic, adds to the analgesic and anti-inflammatory actions of diethylamine salicylate by facilitating its penetration. Myrtecaine also has a muscle relaxant effect.

Chemical Structure

Myrtecaine
Myrtecaine
CAS#7712-50-7 (free base)

Theoretical Analysis

MedKoo Cat#: 464379

Name: Myrtecaine

CAS#: 7712-50-7 (free base)

Chemical Formula: C17H31NO

Exact Mass: 265.2406

Molecular Weight: 265.44

Elemental Analysis: C, 76.92; H, 11.77; N, 5.28; O, 6.03

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
68342-78-9 (HCl); 7712-50-7 (free base)
Synonym
Myrtecaine; Mirtecaina; Myrtecainum; Nopoxamine; Algesal; Algésal Suractivé;
IUPAC/Chemical Name
2-(2-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethoxy)-N,N-diethylethan-1-amine
InChi Key
BZRYYBWNOUALTQ-HOTGVXAUSA-N
InChi Code
InChI=1S/C17H31NO/c1-5-18(6-2)10-12-19-11-9-14-7-8-15-13-16(14)17(15,3)4/h7,15-16H,5-6,8-13H2,1-4H3/t15-,16-/m0/s1
SMILES Code
CCN(CCOCCC1=CC[C@H]2C[C@@H]1C2(C)C)CC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 265.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Wanet G. Etude clinique contrôlée d'un topique associant la nopoxamine au salicylate de diéthylamine (Algésal suractivé) en médecine physique et réhabilitation [Controlled clinical study of a topic associating nopoxamine with diethylamine salicylate (Algésal suractivé) in physical medicine and rehabilitation (author's transl)]. J Belge Med Phys Rehabil. 1979;2(2):119-26. French. PMID: 317713. 2: Parturier-Albot M, Veyne S. Intérêt de l'association du lauryl-sulfate de nopoxamine, du sulfate de galactane et de l'amino acétate basique d'aluminium dans le traitement des douleurs gastro-duodénales [Association of nopoxamine lauryl-sulfate, galactane sulfate and aluminium basic amino-acetate in the treatment of gastro-duodenal pains]. Actual Hepatogastroenterol (Paris). 1969 Aug-Sep;5(5):B231-5. French. PMID: 4188601. 3: Siemieniuk A, Szałkowska-Pagowska H, Lochyński S, Piatkowski K, Filipek B, Krupińska J, Czarnecki R, Librowski T, Szymańska I. Synthesis and some pharmacological properties of 1,2-amino ethers with natural monoterpene structures. Pol J Pharmacol Pharm. 1992 Mar-Apr;44(2):187-200. PMID: 1409119.